ASA Biopharm's Podcast

Inna Perevozskaya and Bo Huang discuss the changing landscape in oncology clinical development. 

Alex Dmitrienko and Kyle Wathen talk about the development of software for biopharmaceutical applications, the new working group and LinkedIn group , and talk a little bit about the new YouTube Channel for the Biopharmaceutical Section.

Zoran Antonijevic, Robert Beckman, Scott Berry & Richard Simon discuss the current application and future of platform trials.  

Qi talks about the benefits and challenges of applying deep learning methodologies to electronic medical records.

Richard discusses the importance of the Biopharmaceutical Section and describes what he hopes to accomplish as Chair in 2019.

Toshimitsu Hamasaki describes his work at a major research hospital and discusses the regulatory environment in Japan.

Hong Liu-Seifert and Steve Wilson discuss the challenges of developing new treatments for Alzheimer's Disease and the formation of the scientific working group.

Pam McGovern, Willis Jensen, John Kolassa, and Fanni Natanegara talk about collaboration and the Statistical Partnerships Among Academe, Industry & Government Committee, otherwise known as SPAIG. 

Shanthi Sethuraman and Haoda Fu discuss challenges and opportunities in using wearable devices for research in diabetes.

Yun and Satrajit discuss the 2018 Regulatory-Industry Statistics Workshop.

Aparna Anderson, David DeMets, Susan Ellenberg, and Janet Wittes discuss the history of data monitoring committees and some of the challenges of implementing them in practice.

Cathy Furlong and Gary Shapiro discuss the history of Statistics Without Borders and how statisticians can use their skills to give back to the community.

Ling Chen and Kunthel By discuss methods related to the development of abuse deterrent opioids.

Zoltan Harsanyi, Janet McDougall, and Theresa Utlaut discuss the PStat® and GStat® accreditations.

Alexander Schacht and Benjamin Piske discuss their new podcast and the many ways statisticians can make themselves more effective.

ASA President Lisa LaVange describes her varied career across industry, government and academia, and discusses the establishment of the ASA Leadership Institute.

Heather discusses her goals for the Biopharmaceutical Section in 2018 and describes the life of a medical product statistician living in a non-traditional area.

Stephen Bamford, Chris Hurley and James Johnson discuss the motivation for and initiatives of PhUSE

Susan Wang and Amy Xia discuss the challenges of pediatric medical product development.

Gheorghe Doros, Anastasia Ivanova, and George Papakostas discuss the Sequential Parallel Comparison Design and the newly-formed Clinical Trial Designs with Re-Randomization of Subjects Scientific Working Group.

Kelly shares her thoughts on real world data and real world evidence in the healthcare and pharmaceutical industry.

Weili and Martin discuss the 2017 Regulatory-Industry Statistics Workshop.

Andy Grieve, Nigel Howitt, John Lewis and Lucy Rowell reminisce about PSI’s past and look forward to its future.

Reneé Moore and Janelle Charles discuss the mission and major initiatives of the Committee on Minorities in Statistics and the many ways statisticians can get involved.

Liz discusses the Health Policy Statistics Section (HPSS) of the ASA, the upcoming 2018 International Conference on Health Policy Statistics (ICHPS), as well as some of the major topic areas of focus for health policy statistics.